N-of-1 (single-patient) trials for Statin-related Myalgia

Annals of Internal Medicine

Volumn 160, Issue 5, 2014, Pages 301-310

  Joy, Tisha R ^a   Monjed, Alaa ^b   Zou, Guang Yong ^c   Hegele, Robert A ^c   McDonald, Charlotte G ^a   Mahon, Jeffrey L ^a  

^a WESTERN UNIVERSITY   (Canada)

^b Robarts Clinical Trials ^*  (Saudi Arabia)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; ATORVASTATIN; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MALE; MYALGIA; PRIORITY JOURNAL; VISUAL ANALOG SCALE; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; CREATINE KINASE BLOOD LEVEL; FEASIBILITY STUDY; FRAMINGHAM RISK SCORE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAIN SEVERITY; PATIENT ASSESSMENT; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; FLUOROBENZENES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MYALGIA; PYRIMIDINES; PYRROLES; RESEARCH DESIGN; SULFONAMIDES;

EID: 84895808601     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/m13-1921     Document Type: Article

References (36)

1. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; American College of Cardiology. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40:567-72. [PMID: 12142128]
2. Bays H. Statin safety: an overview and assessment of the data-2005. Am J Cardiol. 2006;97:6C-26C. [PMID: 16581330]
3. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol. 2006; 97:52C-60C. [PMID: 16581329]
4. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-207. [PMID: 18997196]
5. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al; SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343-56. [PMID: 18765433]
6. Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003;163:553-64. [PMID: 12622602]
7. Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med. 2009;150:858-68. [PMID: 19528564]
8. Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, et al; Scripps Mercy Clinical Research Center. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002;137:581-5. [PMID: 12353945]
9. Lamperti C, Naini AB, Lucchini V, Prelle A, Bresolin N, Moggio M, et al. Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol. 2005;62: 1709-12. [PMID: 16286544]
10. Mahon J, Laupacis A, Donner A, Wood T. Randomised study of n of 1 trials versus standard practice. BMJ. 1996;312:1069-74. [PMID: 8616414]
11. Mahon JL, Laupacis A, Hodder RV, McKim DA, Paterson NA, Wood TE, et al. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest. 1999;115:38-48. [PMID: 9925061]
12. Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med. 2011; 8:161-173. [PMID: 21695041]
13. Guyatt G, Jaeschke R, McGinn T. N-of-1 randomized controlled trials. In: Guyatt G, Rennie D, Meade MO, Cook DJ, eds. User's Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 2nd ed. New York: McGraw-Hill; 2008:179-92.
14. Johannessen T, Fosstvedt D. Statistical power in single subject trials. Fam Pract. 1991;8:384-7. [PMID: 1800206]
15. Bellosta S, Corsini A. Statin drug interactions and related adverse reactions. Expert Opin Drug Saf. 2012;11:933-46. [PMID: 22866966]
16. Cham S, Evans MA, Denenberg JO, Golomb BA. Statin-associated musclerelated adverse effects: a case series of 354 patients. Pharmacotherapy. 2010;30: 541-53. [PMID: 20500044]
17. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009;25:567-79. [PMID: 19812802]
18. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, et al. Assessment of pain. Br J Anaesth. 2008;101:17-24. [PMID: 18487245]
19. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20:309-18. [PMID: 15322437]
20. The University of Texas MD Anderson Cancer Center. The Brief Pain Inventory (BPI). Houston, Texas: The University of Texas MD Anderson Cancer Center; 2013. Accessed at www.mdanderson.org/education-and-research /departments-programs-and-labs/departments-and-divisions/symptom-research /symptom-assessment-tools/brief-pain-inventory.html on 1 November 2013.
21. Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38:633-8. [PMID: 11719741]
22. Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996;27:485-9. [PMID: 8604867]
23. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105-21. [PMID: 18055266]
24. Williams VS, Smith MY, Fehnel SE. The validity and utility of the BPI interference measures for evaluating the impact of osteoarthritic pain. J Pain Symptom Manage. 2006;31:48-57. [PMID: 16442482]
25. Zucker DR, Ruthazer R, Schmid CH. Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J Clin Epidemiol. 2010;63:1312-23. [PMID: 20863658]
26. Zhang H, Plutzky J, Skentzos S, Morrison F, Mar P, Shubina M, et al. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med. 2013;158:526-34. [PMID: 23546564]
27. Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012;6:208-15. [PMID: 22658145]
28. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart. 2002;88:229-33. [PMID: 12181210]
29. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772-9. [PMID: 18371492]
30. Mohaupt MG, Karas RH, Babiychuk EB, Sanchez-Freire V, Monastyrskaya K, Iyer L, et al. Association between statin-associated myopathy and skeletal muscle damage. CMAJ. 2009;181:E11-8. [PMID: 19581603]
31. Fung EC, Crook MA. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge. Cardiovasc Ther. 2012;30:e212-8. [PMID: 21884002]
32. Parker BA, Gregory SM, Lorson L, Polk D, White CM, Thompson PD. A randomized trial of coenzyme Q10 in patients with statin myopathy: rationale and study design. J Clin Lipidol. 2013;7:187-93. [PMID: 23725917]
33. Yelland MJ, Poulos CJ, Pillans PI, Bashford GM, Nikles CJ, Sturtevant JM, et al. N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain. Pain Med. 2009;10:754-61. [PMID: 19453961]
34. Yelland MJ, Nikles CJ, McNairn N, Del Mar CB, Schluter PJ, Brown RM. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials. Rheumatology (Oxford). 2007;46:135-40. [PMID: 16777855]
35. Duan N, Kravitz RL, Schmid CH. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J Clin Epidemiol. 2013;66:S21-8. [PMID: 23849149]
36. Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder. Pediatrics. 2006;117:2040-6. [PMID: 16740846]